BRITISH JOURNAL OF CANCER

AuthorsJoseph S. Baxter; Claudia Montiel Equihua; Jan J. Molenaar; Jamie Aye; Gianni Bisogno; Patricia Blanc; Willemijn Breunis; Julia Chisholm; Jacquelyn Crane; Sam Daems; Laura Danielson; Bram de Wilde; Adam D. Durbin; Felipe Galvez-Cancino; Patrizia Gasparini; Birgit Geoerger; Simone Graham; Bass Hassan; Mark E. Hatley; Delphine Heenen; Christine M. Heske; Simone Hettmer; Elizabeth Hookham; Peter Houghton; Pamela Kearns; Charles Keller; Javed Khan; Fiona Kinnis; David Langenau; Geffen Lass; Corinne Mary Linardic; Leo Mascarenhas; Michael T. Meister; Jonathan Metts; Véronique Minard-Colin; Sapna Oberoi; Daniela Palacios; Abbe Pannucci; Seema Patel; Sheena Patel; Silvia Pomella; Terry Rabbitts; Rossella Rota; Erin Rudzinski; Beat Schäfer; John Jack Shern; Karin Straathof; Rajkumar Venkatramani; Marco Wachtel; Sara Wakeling; Zoë Walters; Sam Warburton; Brenda Weigel; Andrew D. J. Pearson; David Jenkinson; Janet Shipley; Michela Casanova

Affiliations1. LifeArc, London, UK; 2. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; 3. The University of Alabama at Birmingham, Birmingham, USA; 4. Department of Women’s and Children’s Health, University of Padova and Pediatric Hematology Oncology Unit, University Hospital of Padova, Padua, Italy; 5. Imagine for Margo, Paris, France; 6. University Children’s Hospital Zurich, Zürich, Switzerland; 7. The Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK; 8. Children’s Hospital of Philadelphia, Philadelphia, USA; 9. Waterland Private Equity Investments, Antwerp, Belgium; 10. I3h Institute, Université libre de Bruxelles, Brussels, Belgium; 11. Cancer Research UK, London, UK; 12. Ghent University Hospital, Gent, Belgium; 13. St Jude Children’s Research Hospital, Memphis, USA; 14. Laboratory of Immune-Regulation, Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK; 15. Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy; 16. Gustave Roussy, Paris, France; 17. Sir William Dunn School of Pathology, University of Oxford, Oxford, UK; 18. KickCancer Foundation, Brussels, Belgium; 19. Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA; 20. Pediatrics I, Martin-Luther University Halle-Wittenberg, Halle, Germany; 21. UT Health San Antonio, San Antonio, USA; 22. College of Medicine and Health, University of Birmingham, Birmingham, UK; 23. Innovative Therapies for Children and Adolescents with Cancer (ITCC), Paris, France; 24. Children’s Cancer Therapy Development Institute, Hillsboro, USA; 25. Oncogenomics Section, Genetics Branch, Centre for Cancer Research, National Cancer Institute, Bethesda, USA; 26. Massachusetts General Hospital - Charlestown Navy Yard (CNY) Campus, Charlestown, USA; 27. Department of Pediatrics, Duke University School of Medicine, LSRC, Durham, USA; 28. Cedars Sinai, Los Angeles, USA; 29. Johns Hopkins All Children’s Cancer & Blood Disorders Institute, Saint Petersburg, USA; 30. Max Rady College of Medicine, Pediatrics and Child Health, CancerCare Manitoba, University of Manitoba, Winnipeg, Canada; 31. Institute for Systems Analysis and Computer Science “Antonio Ruberti” (IASI), National Research Council (CNR), Rome, Italy; 32. Alice’s Arc, New York City, USA; 33. Cancer Research Horizons, London, UK; 34. Bambino Gesu’ Children’s Hospital, IRCCS, Rome, Italy; 35. The Institute of Cancer Research, Brookes Lawley Building, Centre for Cancer Drug Discovery, Sutton, UK; 36. Indiana University School of Medicine, Indianapolis, USA; 37. Universitäts-Kinderspital Zürich, Eleonorenstiftung, Zürich, Switzerland; 38. Cancer Research, National Cancer Institute, Bethesda, USA; 39. University College London Cancer Institute, Great Ormond Street Biomedical Research Centre, London, UK; 40. Texas Children’s Hospital, Houston, USA; 41. Alice’s Ark, Children’s Cancer Charity, Sevenoaks, UK; 42. Southampton General Hospital, University of Southampton, Southampton, UK; 43. The Institute of Cancer Research, London, UK

AuthorsStig Egil Bojesen

Affiliations1. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2. Department of Clinical Biochemistry, Copenhagen University Hospital, Herlev Gentofte, Copenhagen, Denmark

AuthorsNarimène Houmera; Laurent Genestier; Sarah Huet

Affiliations1. Team Lymphoma Immuno-Biology, Centre International de Recherche en Infectiologie, Lyon, France; 2. Institut des Sciences Pharmaceutiques et Biologiques, Université Claude Bernard Lyon 1, Lyon, France; 3. Service d’hématologie biologique, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France

AuthorsMilit S. Patel; Jeffrey Shi Kai Chan; Nina N. Sanford; Jonas Willmann; Puneeth Iyengar; Edward Christopher Dee

Affiliations1. Department of Molecular Biosciences, The University of Texas at Austin, Austin, USA; 2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, USA; 3. Cardio-Oncology Research Unit, Cardiovascular Analytics Group, School of Nursing and Health Sciences, Hong Kong Metropolitan University, Hong Kong, China; 4. Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, USA; 5. Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA; 6. Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland

AuthorsJian Cao; Fang Zhu; Kongrong Xu; Zhizhong Liu; Lei Chen; Shanshan Lv; Liqing Fan; Jie Guo; Mina Tao; Yanwei Luo; Guoli Li; Hao Bo

Affiliations1. Department of Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China; 2. NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, Institute of Reproductive and Stem Cell Engineering, Xiangya School of Basic Medical Science, Central South University, Changsha, China; 3. Department of Reproductive Medicine, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China; 4. Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, Changsha, China; 5. Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, China; 6. National Institution of Drug Clinical Trial, Xiangya Hospital, Central South University, Changsha, China; 7. Department of Nephrology, Hunan Clinical Research Center for Chronic Kidney Disease, Hunan Provincial People’s Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China; 8. Hunan Engineering Research Center for Prevention, Treatment and Rehabilitation of Kidney Diseases, Changsha, China; 9. Changsha Innovation Center for Integrated Diagnosis and Treatment Technology of Metabolic dysfunction–associated kidney diseases, Changsha, China

AuthorsAhmad Kaviani; Neda Karkeabadi; Borna Farazmand

Affiliations1. Centre hospitalier de l’Université de Montréal, Department of Surgery- Surgical Oncology Service, Montreal, Canada; 2. Breast Diseases Research Center (BDRC), Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 3. Department of Surgical Oncology, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran; 4. Radiation Oncology Research Center (RORC), Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran

AuthorsMarcus Skribek; Maria-Effrosyni Livanou; Ioannis Vathiotis; Viktor Strandman; Axel Thorell; Andreas Koulouris; Konstantinos Syrigos; Simon Ekman; Georgios Tsakonas

Affiliations1. Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; 2. Medical Unit Head-Neck, Lung, Skin Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden; 3. Third Department of Internal Medicine, Sotiria Thoracic Diseases Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece; 4. Laboratory of Translational Oncology, Medical School, University of Crete, Heraklion, Greece